Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

5.1K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Donor- and unit-specific factors influencing hemolysis in stored canine and feline packed red blood cells.

Frontiers in veterinary science·2026
Same author

Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple Sclerosis.

International journal of molecular sciences·2026
Same author

Roadmapping stroke healthcare in Colombia: a comprehensive telestroke network evaluation.

BMC medical informatics and decision making·2026
Same author

PARP2 deficiency impairs pancreatic cancer progression by promoting genomic instability and antitumor immunity.

Science advances·2026
Same author

Increasing Kidney Transplant Volume With Higher Kidney Donor Risk Index Kidneys: A Call for Action in the United States.

Transplantation·2026
Same author

Outcomes of Kidney Transplants From Donors With Stage 3 Acute Kidney Injury Requiring Dialysis: A National Cohort Study.

Clinical transplantation·2026

Related Experiment Video

Updated: Jun 21, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K

Explainable machine learning on baseline MRI predicts multiple sclerosis trajectory descriptors.

Silvia Campanioni1, César Veiga1, José María Prieto-González2,3,4

  • 1Galicia Sur Health Research Institute (IIS Galicia Sur), Cardiovascular Research Group, Vigo, Spain.

Plos One
|July 16, 2024
PubMed
Summary
This summary is machine-generated.

Artificial intelligence (AI) can predict multiple sclerosis (MS) progression using novel trajectory descriptors and baseline Magnetic Resonance Imaging (MRI) scans. This approach enhances diagnostic accuracy and personalized patient management in neurology.

More Related Videos

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

8.9K

Related Experiment Videos

Last Updated: Jun 21, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

8.9K

Area of Science:

  • Neurology
  • Medical Imaging
  • Artificial Intelligence

Background:

  • Multiple sclerosis (MS) presents diagnostic and management challenges.
  • Artificial Intelligence (AI) offers potential for early detection and personalized treatment in MS.
  • Predictive modeling for MS patient evolution is crucial for effective management.

Purpose of the Study:

  • To propose novel Multiple Sclerosis (MS) trajectory descriptors for Machine Learning (ML) models.
  • To assess the capability of ML models in identifying MS trajectory descriptors from baseline Magnetic Resonance Imaging (MRI) data.
  • To evaluate the predictive performance of AI models in forecasting MS patient progression.

Main Methods:

  • Utilized data from 446 MS patients with baseline MRI, Expanded Disability Status Scale (EDSS) measurements, and 1-year follow-up.
  • Developed and evaluated regression and classification XGBoost models to relate MS trajectory descriptors (β1, β2, EDSS(t)) to baseline MRI parameters.
  • Employed Shapley Additive Explanations (SHAP) analysis for model transparency and feature importance identification.

Main Results:

  • AI models, utilizing proposed MS trajectory descriptors and baseline MRI, demonstrated superior prediction of MS progression compared to traditional Multiple Linear Regression (MLR).
  • SHAP analysis successfully identified key features influencing MS progression predictions, enhancing model interpretability.
  • The study confirmed the potential of AI in analyzing baseline MRI for predicting patient evolution in MS.

Conclusions:

  • MS trajectory descriptors are vital for predicting disease progression.
  • Integrating AI analysis with MRI assessments significantly advances predictive capabilities for MS.
  • SHAP analysis provides crucial insights into feature importance, supporting clinical decision-making in MS management.